Xiuxiu Cong

537 total citations
19 papers, 411 citations indexed

About

Xiuxiu Cong is a scholar working on Immunology, Molecular Biology and Biomedical Engineering. According to data from OpenAlex, Xiuxiu Cong has authored 19 papers receiving a total of 411 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 10 papers in Molecular Biology and 9 papers in Biomedical Engineering. Recurrent topics in Xiuxiu Cong's work include Immunotherapy and Immune Responses (8 papers), RNA Interference and Gene Delivery (8 papers) and Nanoplatforms for cancer theranostics (8 papers). Xiuxiu Cong is often cited by papers focused on Immunotherapy and Immune Responses (8 papers), RNA Interference and Gene Delivery (8 papers) and Nanoplatforms for cancer theranostics (8 papers). Xiuxiu Cong collaborates with scholars based in China, Croatia and United States. Xiuxiu Cong's co-authors include Tianmeng Sun, Yong‐Guang Yang, Jialiang Wang, Kuirong Mao, Hongmei Chen, Chenxi Wu, Xiandi Meng, Shuhan Liu, Xianzhu Yang and Ge Zhu and has published in prestigious journals such as Biomaterials, ACS Applied Materials & Interfaces and Small.

In The Last Decade

Xiuxiu Cong

17 papers receiving 409 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiuxiu Cong China 9 183 171 119 113 67 19 411
Kuirong Mao China 11 242 1.3× 208 1.2× 141 1.2× 131 1.2× 77 1.1× 25 492
Lujia Huang China 9 183 1.0× 148 0.9× 79 0.7× 150 1.3× 87 1.3× 14 400
Yinping Sun China 11 174 1.0× 162 0.9× 145 1.2× 67 0.6× 57 0.9× 20 394
Xiayi Liang China 11 222 1.2× 112 0.7× 80 0.7× 84 0.7× 46 0.7× 16 393
Aiyan Hu China 8 192 1.0× 116 0.7× 108 0.9× 75 0.7× 49 0.7× 10 361
Hsi‐Chien Huang Taiwan 10 186 1.0× 269 1.6× 108 0.9× 152 1.3× 75 1.1× 15 520
Yiwei Peng China 7 215 1.2× 228 1.3× 73 0.6× 134 1.2× 43 0.6× 13 419
Feiyang Jin China 10 245 1.3× 134 0.8× 117 1.0× 98 0.9× 48 0.7× 14 424
Menghao Shi China 12 277 1.5× 189 1.1× 180 1.5× 89 0.8× 77 1.1× 14 444
Huaqin Zuo China 9 280 1.5× 192 1.1× 152 1.3× 73 0.6× 77 1.1× 14 481

Countries citing papers authored by Xiuxiu Cong

Since Specialization
Citations

This map shows the geographic impact of Xiuxiu Cong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiuxiu Cong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiuxiu Cong more than expected).

Fields of papers citing papers by Xiuxiu Cong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiuxiu Cong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiuxiu Cong. The network helps show where Xiuxiu Cong may publish in the future.

Co-authorship network of co-authors of Xiuxiu Cong

This figure shows the co-authorship network connecting the top 25 collaborators of Xiuxiu Cong. A scholar is included among the top collaborators of Xiuxiu Cong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiuxiu Cong. Xiuxiu Cong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
2.
3.
Mao, Kuirong, Hongmei Chen, Xiuxiu Cong, et al.. (2024). Enhancing the Safety and Efficacy of Trastuzumab Emtansine (T‐DM1) Through Nano‐Delivery System in Breast Cancer Therapy. Small. 20(50). e2400977–e2400977. 1 indexed citations
4.
Cong, Xiuxiu, et al.. (2024). Nanocarriers for targeted drug delivery in the vascular system: focus on endothelium. Journal of Nanobiotechnology. 22(1). 620–620. 28 indexed citations
5.
Mao, Kuirong, Xiuxiu Cong, Ji Liu, et al.. (2024). Optimized lipid nanoparticles enable effective CRISPR/Cas9-mediated gene editing in dendritic cells for enhanced immunotherapy. Acta Pharmaceutica Sinica B. 15(1). 642–656. 7 indexed citations
6.
Cong, Xiuxiu, Yue Lv, Kuirong Mao, et al.. (2024). Impacts of cationic lipid–DNA complexes on immune cells and hematopoietic cells in vivo. Biomaterials Science. 12(9). 2381–2393. 1 indexed citations
7.
Zhang, Yuning, He Li, Xue Gao, et al.. (2023). Co-delivery of vitamin D3 and Lkb1 siRNA by cationic lipid-assisted PEG-PLGA nanoparticles to effectively remodel the immune system in vivo. Biomaterials Science. 11(17). 5931–5941. 4 indexed citations
8.
Meng, Xiandi, Kuirong Mao, Hongmei Chen, et al.. (2023). Maleimide as the PEG end-group promotes macrophage-targeted drug delivery of PEGylated nanoparticles in vivo by enhancing interaction with circulating erythrocytes. Biomaterials. 300. 122187–122187. 20 indexed citations
9.
Gao, Xue, Xiuxiu Cong, He Li, et al.. (2023). 212 Co‐delivery of Vitamin D3 and Antigens by Nanoparticles Enhances Immune Tolerance through Induction of Tolerogenic Dendritic Cells in vivo. Advanced Therapeutics. 6(7). 1 indexed citations
10.
Mao, Kuirong, Xiuxiu Cong, Feiqi Liu, et al.. (2023). In Vivo Immune Adjuvant Effects of CaCO3 Nanoparticles through Intracellular Ca2+ Concentration Regulation. ACS Applied Materials & Interfaces. 15(33). 39157–39166. 8 indexed citations
11.
Liu, Shuhan, Ji Liu, Haisong Li, et al.. (2022). An optimized ionizable cationic lipid for brain tumor-targeted siRNA delivery and glioblastoma immunotherapy. Biomaterials. 287. 121645–121645. 92 indexed citations
12.
Wang, Jialiang, Kuirong Mao, Xiuxiu Cong, et al.. (2022). Nanoparticle delivery of CD40 siRNA suppresses alloimmune responses by inhibiting activation and differentiation of DCs and macrophages. Science Advances. 8(51). eabq3699–eabq3699. 15 indexed citations
13.
Cong, Xiuxiu, Jialiang Wang, Kuirong Mao, et al.. (2022). Kidney functional stages influence the role of PEG end-group on the renal accumulation and distribution of PEGylated nanoparticles. Nanoscale. 14(26). 9379–9391. 8 indexed citations
14.
Li, Yong, Xianying Meng, Xuan Wu, et al.. (2022). Lipid-mediated delivery of CD47 siRNA aids JQ1 in ensuring simultaneous downregulation of PD-L1 and CD47 and improves antitumor immunotherapy efficacy. Biomaterials Science. 10(23). 6755–6767. 7 indexed citations
15.
Chen, Hongmei, Xiuxiu Cong, Chenxi Wu, et al.. (2020). Intratumoral delivery of CCL25 enhances immunotherapy against triple-negative breast cancer by recruiting CCR9 + T cells. Science Advances. 6(5). eaax4690–eaax4690. 70 indexed citations
16.
Sun, Xu, Ziyang Cao, Kuirong Mao, et al.. (2020). Photodynamic therapy produces enhanced efficacy of antitumor immunotherapy by simultaneously inducing intratumoral release of sorafenib. Biomaterials. 240. 119845–119845. 69 indexed citations
17.
Cong, Xiuxiu, Huimin Tian, Kuirong Mao, et al.. (2020). Cationic Liposome/DNA Complexes Mediate Antitumor Immunotherapy by Promoting Immunogenic Tumor Cell Death and Dendritic Cell Activation. ACS Applied Materials & Interfaces. 12(25). 28047–28056. 38 indexed citations
18.
Mao, Kuirong, Xiuxiu Cong, Liangzhu Feng, et al.. (2019). Intratumoral delivery of M-CSF by calcium crosslinked polymer micelles enhances cancer immunotherapy. Biomaterials Science. 7(7). 2769–2776. 30 indexed citations
19.
Wu, Chenxi, Hongmei Chen, Xuan Wu, et al.. (2017). The influence of tumor-induced immune dysfunction on the immune cell distribution of gold nanoparticles in vivo. Biomaterials Science. 5(8). 1531–1536. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kuirong Mao Breakdown of academic impact, for papers by Lujia Huang Breakdown of academic impact, for papers by Yinping Sun Breakdown of academic impact, for papers by Xiayi Liang Breakdown of academic impact, for papers by Aiyan Hu Breakdown of academic impact, for papers by Hsi‐Chien Huang Breakdown of academic impact, for papers by Yiwei Peng Breakdown of academic impact, for papers by Feiyang Jin Breakdown of academic impact, for papers by Menghao Shi Breakdown of academic impact, for papers by Huaqin Zuo
Rankless by CCL
2026